Professor Ingram received his M.D. from Vanderbilt University School of Medicine, 1994; Internship and Residency at University of California and San Francisco, 1994 - 1997; and Fellowship at Indiana University School of Medicine, 1998 - 2002.
Dr. Ingram's academic interests involve two distinct areas of investigation. First, Dr. Ingram's laboratory utilizes genetically engineered mouse models to study tumor angiogenesis in childhood cancers and the development of vascular malformations in children with genetic mutations in the Ras-Erk signaling pathway. Second, his laboratory studies the biology of endothelial progenitor cells and myeloid precursors in repairing damaged blood vessels in the setting of ischemic injury and impaired vasculogenesis during development. Dr. Ingram's laboratory has also developed techniques to isolate and expand endothelial progenitor cells from human umbilical cord blood for potential use in regeneration of damaged blood vessels. Based on this work, Dr. Ingram directs the National Cancer Institute funded Angiogenesis and Endothelial Progenitor Cell Core at the Indiana University Cancer Center.